KALA vs NVR · $54.3M cap vs P/E 15, rev $4.21B
Kala Pharmaceuticals Inc (KALA) versus NVR Inc (NVR) — a side-by-side from cached financials, not a winner call.
Kala Pharmaceuticals Inc (KALA) is a biotechnology company listed on NASDAQ.
NVR Inc (NVR) is a residential construction company listed on NYSE.
Latest reported KALA revenue for 2025-12-31 was $0. Net income was -$27.0M. KALA currently screens at market cap $54.3M.
Latest reported NVR revenue for 2026-06-30 was $4.21B. Net income was $434.8M. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
KALA currently screens at market cap $54.3M. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
Not investment advice. Open the KALA and NVR stock pages for the full models.
Not investment advice.